Alternative sequencing of FOLFIRI or mFOLFOX6 with erlotinib in the second-line treatment of metastatic colorectal cancer (mCRC): An ongoing phase II trial.
Charles D. Lopez
Honoraria - Genentech
Research Funding - Genentech
Gina M. Vaccaro
Other Remuneration - Pfizer
Kerstin M Kampa-Schittenhelm
No relevant relationships to disclose
John M. Strother
No relevant relationships to disclose
Andrea Burt
No relevant relationships to disclose
Jeff Masterson
No relevant relationships to disclose